Status:
RECRUITING
Betamethasone and Closure of Ductus Arteriosus
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Persistent Ductus Arteriosus
Eligibility:
All Genders
1+ years
Brief Summary
The ductus arteriosus (DA) normally closes after birth as a result of exposure to oxygen. Its persistence of DA (PDA) occurs in 20 to 50% of very preterm infants and is associated with significant mor...
Eligibility Criteria
Inclusion
- Inclusion Criteria :
- born between January 2018 and December 2022
- at a gestational age below 37 weeks,
- hospitalized in the Neonatal unit of Croix-Rousse hospital,
- presenting a hemodynamically significant DA
- treated by BTM for bronchopulmonary dysplasia
- Exclusion Criteria :
- Children having closed their ductus arteriosus before administration of the betamethasone course
- Children who died before or during treatment.
Exclusion
Key Trial Info
Start Date :
May 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT05987202
Start Date
May 1 2023
End Date
December 1 2024
Last Update
January 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Réanimation néonatale - Hôpital de la Croix Rousse
Lyon, France, 69317